• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM; CORONARY ATHERECTOMY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARDIOVASCULAR SYSTEMS, INC. DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM; CORONARY ATHERECTOMY DEVICE Back to Search Results
Model Number DBEC-125
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Hematoma (1884); Hemorrhage, Subdural (1894); Sepsis (2067); Perforation of Vessels (2135); No Code Available (3191)
Event Date 02/15/2019
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive since the reported device was not returned for analysis.Based on the information received, the cause of the reported event could not be conclusively determined.The device history record for the reported oad was unable to be reviewed, as the lot number was not provided.(b)(4).
 
Event Description
During a procedure using a diamondback orbital atherectomy device (oad), a perforation occurred, and the patient later passed away.An 80% stenosed, heavily calcified lesion was treated in the right coronary artery (rca).Three treatment passes were performed on low speed and one treatment pass was performed on high speed.An acute, type iii coronary perforation was observed, and a 3.0x20mm balloon was inflated to occlude flow.Two covered stents and one drug-eluting stent were placed, resolving the perforation.The drug-eluting stent was somewhat deformed from the calcification at the lesion site but was patent.The was a small to moderate pericardial effusion with intrapericardial hematoma observed, but there was no evidence of cardiac tamponade.After stent placement, slow flow was observed, and adenosine was administered.Final angiography showed optimal results.The patient was transferred to the intensive care unit after the procedure.Three days later, the patient passed away due to a bilateral subdural bleed.It was believed the bleed was caused by anticoagulation from the covered stent placement.
 
Manufacturer Narrative
Csi id# (b)(4).
 
Event Description
During a procedure using a diamondback orbital atherectomy device (oad), a perforation occurred, and the patient later expired.An 80% stenosed, heavily calcified lesion was treated in the right coronary artery (rca).Three treatment passes were performed on low speed and one treatment pass was performed on high speed.An acute, type iii coronary perforation was observed, and a 3.0x20mm balloon was inflated to occlude flow.Two covered stents and one drug-eluting stent were placed, resolving the perforation.The drug-eluting stent was somewhat deformed from the calcification at the lesion site but was patent.There was a small to moderate pericardial effusion with intrapericardial hematoma observed, but there was no evidence of cardiac tamponade.After stent placement, slow flow was observed, and adenosine was administered.Final angiography showed optimal results.The patient was transferred to the intensive care unit after the procedure with some hemodynamic concerns.An iapb was in place, and the patient went into sepsis.Three days after the procedure, the patient became unresponsive and a ct scan showed a bilateral subdural bleed.The patient's pupils were blown, and the patient expired.It was believed the bleed was caused by anticoagulation from the covered stent placement.
 
Manufacturer Narrative
Csi id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIAMONDBACK 360 CORONARY ORBITAL ATHERECTOMY SYSTEM
Type of Device
CORONARY ATHERECTOMY DEVICE
Manufacturer (Section D)
CARDIOVASCULAR SYSTEMS, INC.
1225 old highway 8 nw
saint paul MN 55112
MDR Report Key8365811
MDR Text Key136984810
Report Number3004742232-2019-00060
Device Sequence Number1
Product Code MCX
Combination Product (y/n)N
PMA/PMN Number
P130005
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 03/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberDBEC-125
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/19/2019
Initial Date FDA Received02/25/2019
Supplement Dates Manufacturer Received02/22/2019
02/19/2019
Supplement Dates FDA Received02/28/2019
03/01/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Required Intervention;
Patient Age70 YR
-
-